Overview

Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA)

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of using lumiracoxib in the treatment of patients with knee osteoarthritis (OA)
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Celecoxib
Diclofenac
Lumiracoxib